Search Results - "van den Hoogen, Martijn"

Refine Results
  1. 1

    Successful Treatment of Severe Hyperammonaemia with Ultra-High Dose Continuous Veno-Venous Haemodiafiltration by Boer, Dirk P, Mourik, Sarah L, van den Hoogen, Martijn W F, Langendonk, Janneke G, de Geus, Hilde R H

    Published in Blood purification (01-10-2019)
    “…Hyperammonaemia is a severe condition and often requires a multimodal treatment regimen. Dialysis has been described as a potential treatment option, but…”
    Get more information
    Journal Article
  2. 2

    Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy by Kamburova, Elena G, Koenen, Hans J P M, van den Hoogen, Martijn W F, Baas, Marije C, Joosten, Irma, Hilbrands, Luuk B

    Published in PloS one (13-11-2014)
    “…Prevention of rejection after renal transplantation requires treatment with immunosuppressive drugs. Data on their in vivo effects on T- and B-cell phenotype…”
    Get full text
    Journal Article
  3. 3

    Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection by van der Zwan, Marieke, Clahsen-Van Groningen, Marian C, van den Hoogen, Martijn W F, Kho, Marcia M L, Roodnat, Joke I, Mauff, Katya A L, Roelen, Dave L, van Agteren, Madelon, Baan, Carla C, Hesselink, Dennis A

    Published in Frontiers in immunology (03-07-2020)
    “…Rabbit anti-thymocyte globulin (rATG) is currently the treatment of choice for glucocorticoid-resistant, recurrent, or severe acute allograft rejection (AR)…”
    Get full text
    Journal Article
  4. 4

    Costimulation Blockade in Kidney Transplant Recipients by van der Zwan, Marieke, Hesselink, Dennis A., van den Hoogen, Martijn W. F., Baan, Carla C.

    Published in Drugs (New York, N.Y.) (01-01-2020)
    “…Costimulation between T cells and antigen-presenting cells is essential for the regulation of an effective alloimmune response and is not targeted with the…”
    Get full text
    Journal Article
  5. 5

    Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users by Bakhriansyah, Mohammad, Souverein, Patrick C, van den Hoogen, Martijn W F, de Boer, Anthonius, Klungel, Olaf H

    “…Nonsteroidal anti-inflammatory drugs (NSAIDs) have been associated with AKI. Their association with nephrotic syndrome has not been systematically studied…”
    Get full text
    Journal Article
  6. 6

    Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation by van den Hoogen, Martijn W F, Hoitsma, Andries J, Hilbrands, Luuk B

    Published in Expert opinion on biological therapy (01-08-2012)
    “…Given the central role of T cells in the alloimmune response, anti-T-cell antibodies retain a prominent place in the treatment of renal allograft rejection…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Use of monoclonal antibodies in renal transplantation by van den Hoogen, Martijn W F, Hilbrands, Luuk B

    Published in Immunotherapy (01-07-2011)
    “…Monoclonal antibodies are applied in various settings in renal transplantation. Depleting T-cell antibodies are used for treatment of steroid-resistant acute…”
    Get more information
    Journal Article
  9. 9

    Endothelial Cell Replacement of Human Veins, Modeling Vascular Repair and Endothelial Cell Chimerism by Tejeda-Mora, Hector, den Hartog, Yvette, Schurink, Ivo J, Verstegen, Monique M A, de Jonge, Jeroen, van den Hoogen, Martijn W F, Baan, Carla C, Minnee, Robert C, Hoogduijn, Martin J, van der Laan, Luc J W, Willemse, Jorke

    Published in Stem cells and development (01-01-2024)
    “…Allogeneic transplant organs are potentially highly immunogenic. The endothelial cells (ECs) located within the vascular system serve as the primary interface…”
    Get more information
    Journal Article
  10. 10
  11. 11

    The effects of in vivo B-cell depleting therapy on ex-vivo cytokine production by Smeekens, Sanne P, van den Hoogen, Martijn W.F, Kamburova, Elena G, van de Veerdonk, Frank L, Joosten, Irma, Koenen, Hans J.M.P, Netea, Mihai G, Hilbrands, Luuk B, Joosten, Leo A.B

    Published in Transplant immunology (01-06-2013)
    “…Abstract In renal transplantation, IL-17 production by T-cells might be dependent on the presence of B-cells. Therefore, the effect of in vivo B-cell depletion…”
    Get full text
    Journal Article
  12. 12

    Disparities in kidney transplantation accessibility among immigrant populations in Europe: A systematic review and meta-analysis by van Overdijk, Pieter A H, Grossi, Alessandra A, van Delft, Céline H, Jansen, Nichon E, van den Hoogen, Martijn W F, Paredes-Zapata, David

    “…Disparities in access to healthcare for patients with an immigration background are well-known. The aim of this study was to determine whether disparities…”
    Get full text
    Journal Article
  13. 13

    Use of the Platelet Function Analyzer to minimize bleeding complications after renal biopsy by van den Hoogen, Martijn W.F, Verbruggen, Bert W, Polenewen, Robert, Hilbrands, Luuk B, Nováková, Irena R.O

    Published in Thrombosis research (01-01-2009)
    “…Abstract Background The bleeding time is frequently used to screen primary haemostasis before surgical procedures, although it poorly predicts the risk of…”
    Get full text
    Journal Article
  14. 14

    A comparison between combined liver kidney transplants to liver transplants alone: A systematic review and meta-analysis by Bouari, Sarah, Rijkse, Elsaline, Metselaar, Herold J., van den Hoogen, Martijn W.F., IJzermans, Jan N.M., de Jonge, Jeroen, Polak, Wojciech G., Minnee, Robert C.

    “…Since the introduction of the Model for End-stage Liver disease criteria in 2002, more combined liver kidney transplants are performed. Until 2017, no standard…”
    Get full text
    Journal Article
  15. 15

    New possibilities on transplanting kidneys from hepatitis C virus positive donors: a Systematic Review by van Riet, Renske C., van Dijk, Kiki M., van den Hoogen, Martijn W.F.

    “…•Donor hepatitis C infection is associated with worse survival in kidney transplant recipients•Waitlisted patients have a worse patient survival compared to…”
    Get full text
    Journal Article
  16. 16

    Cytokine Release After Treatment With Rituximab in Renal Transplant Recipients by Kamburova, Elena G, van den Hoogen, Martijn W F, Koenen, Hans J P M, Baas, Marije C, Hilbrands, Luuk B, Joosten, Irma

    Published in Transplantation (01-09-2015)
    “…Treatment with rituximab may be accompanied by a systemic cytokine release. We studied the effects of a single dose of rituximab on cytokine levels in…”
    Get full text
    Journal Article
  17. 17

    Rituximab in Membranous Nephropathy by Gauckler, Philipp, Shin, Jae Il, Alberici, Federico, Audard, Vincent, Bruchfeld, Annette, Busch, Martin, Cheung, Chee Kay, Crnogorac, Matija, Delbarba, Elisa, Eller, Kathrin, Faguer, Stanislas, Galesic, Kresimir, Griffin, Siân, van den Hoogen, Martijn W.F., Hrušková, Zdenka, Jeyabalan, Anushya, Karras, Alexandre, King, Catherine, Kohli, Harbir Singh, Mayer, Gert, Maas, Rutger, Muto, Masahiro, Moiseev, Sergey, Odler, Balazs, Pepper, Ruth J., Quintana, Luis F., Radhakrishnan, Jai, Ramachandran, Raja, Salama, Alan D., Schönermarck, Ulf, Segelmark, Mårten, Smith, Lee, Tesař, Vladimír, Wetzels, Jack, Willcocks, Lisa, Windpessl, Martin, Zand, Ladan, Zonozi, Reza, Kronbichler, Andreas, Gauckler, Philipp, Shin, Jae Il, Alberici, Federico, Audard, Vincent, Bruchfeld, Annette, Busch, Martin, Cheung, Chee Kay, Crnogorac, Matija, Delbarba, Elisa, Eller, Kathrin, Faguer, Stanislas, Galesic, Kresimir, Griffin, Siân, van den Hoogen, Martijn W.F., Hrušková, Zdenka, Jeyabalan, Anushya, Karras, Alexandre, King, Catherine, Kohli, Harbir Singh, Mayer, Gert, Maas, Rutger, Muto, Masahiro, Moiseev, Sergey, Odler, Balazs, Pepper, Ruth J., Quintana, Luis F., Radhakrishnan, Jai, Ramachandran, Raja, Salama, Alan D., Schönermarck, Ulf, Segelmark, Mårten, Smith, Lee, Tesař, Vladimír, Wetzels, Jack, Willcocks, Lisa, Windpessl, Martin, Zand, Ladan, Zonozi, Reza, Kronbichler, Andreas

    Published in Kidney international reports (01-04-2021)
    “…Membranous nephropathy (MN) is the most common cause of primary nephrotic syndrome among adults. The identification of phospholipase A2 receptor (PLA2R) as…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome by van den Hoogen, Martijn W.F., Steenbergen, Eric J., Baas, Marije C., Florquin, Sandrine, Hilbrands, Luuk B.

    Published in Transplantation direct (01-04-2017)
    “…The pathophysiological role of intragraft B cells during renal allograft rejection is unclear. We studied B-cell infiltration during acute rejection in 53…”
    Get full text
    Journal Article
  20. 20